TOXICOLOGY &

SPECIAL MODULE
3rd Professional MBBS (Session 2019-20)

Note: Given below is the sequence of the calendar that would be followed normally.
Saturday of the same week will be utilized to compensate any unscheduled holiday.
Abbreviations used: SDL, Self-directed Learning; DSL, Directed Self Learning; SGD, Small Group Discussion;
P, Practical; Patho, Pathology; F Med, Forensic Medicine; Pharma, Pharmacology; Ophth, Ophthalmology;
C Med, Community Medicine; ORL, Otorhinolaryngology (ENT); Derm, Dermatology; SLRC, Self-Learning Resource Centre
Division for Practicals & DSLs: Batch A1: 1-62; Batch A2: 63-125; Batch B1: 126-187; Batch B2: 188-250 and onward.
Division for SGDs: Group 1: 1-42; Group 2: 43-84; Group 3: 85-125; Group 4: 126-167; Group 5: 168-209; Group 6: 210-250 and onward
 RD
TIME TABLE OF TOXICOLOGY & SPECIAL MODULE FOR 3 YEAR MBBS (SESSION 2019-20)
WEEK 1
11:00 am - 01:00 -
Day/Date 08:00 - 09:00 am 09:00 - 10:00 am 10:00 - 11:00 am 01:30 - 03:00 pm
01:00 pm 01:30 pm
THEME 1: POISONS & TOXINS
F Med-L2
Pharma P1- Batch A1: Dr Mustafa (Pharma-17)
F Med-L1 Factors affecting actions of
Pharma-L1 Batch A2: SDL
Introduction to Toxicology; poisons; Diagnosis of poisoning;
Mon Adverse Drug Reactions
Role of Forensic Toxicologist Duties of a Doctor
13/04/2020 Dr Saleh F Med DSL1
Dr Naveed in case of poisoning
(Pharma-13) Batch B1: Dr Beenish (Pharma-14)
(Pharma-13) Dr Naveed
Batch B2: Dr Saad (Pharma-18)
(Pharma-13)

H O S P I T A L

P R A Y E R
F Med-L3 Pharma P1- Batch B1: Dr Tamhid (Pharma-17)
PRIME-L1 F Med-L4
Poisoning due to corrosives- Batch B2: SDL
Med Education Classification of Irritants-
Tue Sulphuric acid; Nitric acid;
Doctor Patient Relationship Phosphorus & Arsenic poisoning
14/04/2020 Carbolic acid; Oxalic acid F Med DSL1
Prof Farooq Dr Shahida
Dr Naveed Batch A1: Dr Saad (Pharma-18)
(Pharma-13) (Pharma-13)
(Pharma-13) Batch A2: Dr Beenish (Pharma-14)

B R E A K
Pharma-L2 F Med-L6 Pharma P1- Batch A2: Dr Mustafa (Pharma-17)
F Med-L5
Remedial class in General Poisoning due to Abrus Batch A1: SDL

W O R K
Lead, Mercury &
Wed Pharmacology; Viva Preparation precatorius, Capsicum &
Thallium poisoning
15/04/2020 in General Pharmacology Semecarpus anacardium F Med DSL2
Dr Shahida
Prof Mushtaq Dr Shahida Batch B1: Dr Sahib Dad (Pharma-14)
(Pharma-13)
(Pharma-13) (Pharma-13) Batch B2: Dr Saad (Pharma-16)

F Med-L7 Pharma P1- Batch B2: Dr Tamhid (Pharma-17)

Pharma-L3 F Med-L8
Poisoning due to Batch B1: SDL
Viva preparation in Toxicity due to
Thu Croton tiglium & Colocynth;
Autonomic Nervous System Dhatura & Cannabis
16/04/2020 Snake bite F Med DSL2
Prof Mushtaq Dr Yousaf
Dr Shahida Batch A1: Dr Sahib Dad (Pharma-14)
(Pharma-13) (Pharma-13)
(Pharma-13) Batch A2: Dr Saad (Pharma-16)

10:00 am - 12:30 pm 12:30 - 02:00 pm 02:00 - 03:00 pm

F Med-L9
Pharma-L4
Toxicity due to
Fri Viva preparation in CVS
Opium and its derivatives JUMMA SDL
17/04/2020 Prof Mushtaq H O S P I T A L W O R K
Dr Yousaf PRAYER (SLRC/Library)
(Pharma-13)
(Pharma-13)

F Med DSL1- Sampling in a poisoned patient Pharma P1- To prepare and dispense 50 ml of 0.1% KMnO4 solution
F Med DSL2- Preservation and chain of custody of toxicology samples
 RD
TIME TABLE OF TOXICOLOGY & SPECIAL MODULE FOR 3 YEAR MBBS (SESSION 2019-20)
WEEK 2
11:00 am - 01:00 -
Day/Date 08:00 - 09:00 am 09:00 - 10:00 am 10:00 - 11:00 am 01:30 - 03:00 pm
01:00 pm 01:30 pm
THEME 1: POISONS & TOXINS
Pharma P2- Batch A1: Dr Tahira (Pharma-17)
F Med-L10 F Med-L11
Pharma-L5 Batch A2: SDL
Toxicity due to Alcohols, Toxicity due to
Viva preparation in
Mon Sedative-hypnotics & Spinal Stimulants and
Renal & Respiratory Systems F Med SGD1
20/04/2020 Petroleum distillates Depressants
Prof Mushtaq Group 4: Dr Sahib Dad (Patho-21)
Dr Yousaf Dr Yousaf
(Pharma-13) Group 5: Dr Saad (Patho-22)
(Pharma-13) (Pharma-13)
Group 6: Dr Beenish (Patho-23)

H O S P I T A L

P R A Y E R
Pharma P2- Batch B1: Dr Obaida (Pharma-17)
Med-L1 F Med-L13 Batch B2: SDL
F Med-L12
General Management of Remedial class;
Tue Toxicity due to Asphyxiants
A poisoned patient Agricultural poisons F Med SGD1
21/04/2020 Dr Yousaf
Dr Haroon Dr Yousaf Group 1: Dr Sahib Dad (Patho-21)
(Pharma-13)
(Pharma-13) (Pharma-13) Group 2: Dr Saad (Patho-22)
Group 3: Dr Beenish (Patho-23)
THEME 2: IDENTITY & IDENTIFICATION

B R E A K
Pharma P2- Batch A2: Dr Tahira (Pharma-17)
F Med-L14 PRIME-L2 F Med-L15

W O R K
Batch A1: SDL
Introduction to Med Education Sex determination;
Wed
personal identity Professional Identity formation Intersex states
22/04/2020 F Med DSL3
Dr Naveed Prof Farooq Dr Naveed
Batch B1: Dr Sahib Dad (Pharma-14)
(Pharma-13) (Pharma-13) (Pharma-13)
Batch B2: Dr Beenish (Pharma-16)
Pharma P2- Batch B2: Dr Obaida (Pharma-17)
F Med-L16 F Med-L17
Pharma-L6 Batch B1: SDL
Comparison of male and Age determination and its
Thu Viva preparation in CNS I
female skeletons medicolegal significance
23/04/2020 Prof Mushtaq F Med DSL3
Dr Naveed Dr Naveed
(Pharma-13) Batch A1: Dr Beenish (Pharma-16)
(Pharma-13) (Pharma-13)
Batch A2: Dr Sahib Dad (Pharma-14)
10:00 am - 12:30 pm 12:30 - 02:00 pm 02:00 - 03:00 pm
F Med-L18
Pharma-L7
Anthropometry;
Fri Viva preparation in CNS II
Forensic Odontology JUMMA SDL
24/04/2020 Prof Mushtaq H O S P I T A L W O R K
Dr Naveed PRAYER (SLRC/Library)
(Pharma-13)
(Pharma-13)

F Med SGD1- How to issue an age certificate Pharma P2- To prepare and dispense 40 ml of Turpentine oil liniment
F Med DSL3- Identity of gender in skeletonized body
 RD
TIME TABLE OF TOXICOLOGY & SPECIAL MODULE FOR 3 YEAR MBBS (SESSION 2019-20)
WEEK 3
Ramadan 10:15 -
08:00 - 08:45 am 08:45 - 09:30 am 09:30 - 10:15 am 11:45 am - 01:00 pm
Timings 11:45 am
THEME 2: IDENTITY & IDENTIFICATION
Pharma P3- Batch A1: Mr Waheed (Pharma-17)
F Med-L19
F Med-L20 Batch A2: SDL
Dactylography; Pharma-L8
Identification in
Mon Scars, tattoos and Viva preparation in CNS III
mass disasters F Med SGD2
27/04/2020 professional stigmata Prof Mushtaq
Dr Naveed Group 4: Dr Sahib Dad (Pharma-15)
Dr Naveed (Pharma-13)
(Pharma-13) Group 5: Dr Saad (Pharma-16)
(Pharma-13)
Group 6: Dr Beenish (Pharma-18)
Pharma P3- Batch B1: Dr Tariq (Pharma-17)

H O S P I T A L
Pharma-L9 Batch B2: SDL
F Med-L21 F Med-L22
Viva preparation in
Tue DNA profiling and sampling Trace evidence
Endocrine System I F Med SGD2
28/04/2020 Mr Jamil Dr Shahida
Prof Mushtaq Group 1: Dr Sahib Dad (Pharma-15)
(Pharma-13) (Pharma-13)
(Pharma-13) Group 2: Dr Saad (Pharma-16)
Group 3: Dr Beenish (Pharma-18)

Pharma P3- Batch A2: Mr Waheed (Pharma-17)

F Med-L23 Pharma-L10 F Med-L24
Batch A1: SDL
Medicolegal examination Viva preparation in Medicolegal examination
Wed

W O R K
of blood Endocrine System II of semen
29/04/2020 F Med DSL4
Dr Shahida Prof Mushtaq Dr Shahida
Batch B1: Dr Saad (Pharma-14)
(Pharma-13) (Pharma-13) (Pharma-13)
Batch B2: Dr Beenish (Pharma-16)

Pharma P3- Batch B2: Dr Tariq (Pharma-17)

F Med-L26
F Med-L25 Pharma-L11 Batch B1: SDL
Introduction to
Medicolegal examination Viva preparation in
Thu Medical Jurisprudence;
of hair and fibre GIT & miscellaneous topics F Med DSL4
30/04/2020 Medical negligence
Dr Shahida Prof Mushtaq Batch A1: Dr Saad (Pharma-14)
Dr Naveed
(Pharma-13) (Pharma-13) Batch A2: Dr Beenish (Pharma-16)
(Pharma-13)

Fri
01/05/2020 L A B O U R D A Y

F Med SGD2- Medicolegal importance of trace evidence Pharma P3- To prepare and dispense 60 ml of 12.5% Castor oil emulsion
F Med DSL4- Role of fingerprints and iris in personal identity
 RD
TIME TABLE OF TOXICOLOGY & SPECIAL MODULE FOR 3 YEAR MBBS (SESSION 2019-20)
WEEK 4
Ramadan 10:15 -
08:00 - 08:45 am 08:45 - 09:30 am 09:30 - 10:15 am 11:45 am - 01:00 pm
Timings 11:45 am
THEME 2: IDENTITY & IDENTIFICATION
Pharma P4- Batch A1: Dr Tamhid (Pharma-17)
F Med-L27 PRIME-L3
Batch A2: SDL
Duties of a Registered Medical Med Education F Med-L28
Mon Officer; Professional secrecy and Medical ethics & PM&DC and its functions
Patho SGD 1
04/05/2020 privilege communication Professional misconduct Dr Naveed
Group 4: Dr Mohsin (Patho-21)
Dr Naveed Prof Farooq (Pharma-13)
Group 5: Dr Zarmina (Patho-22)
(Pharma-13) (Pharma-13)
Group 6: Dr Maria (Patho-23)
THEME 3: BLOOD CLOT & “CANCER”

H O S P I T A L
Pharma P4
Batch B1: Dr Tahira (Pharma-17)
Physio-L1 Pharma-L12
Patho-L1 Batch B2: SDL
A review of clotting and Anti-coagulants
Tue Nomenclature of Tumors
coagulation physiology (Parenteral and oral )
05/05/2020 Prof Ahmad Rafiq Patho SGD 1
Dr Aslam Dr Saleh
(Pharma-13) Group 1: Dr Mohsin (Patho-21)
(Pharma-13) (Pharma-13)
Group 2: Dr Zarmina (Patho-22)
Group 3: Dr Maria (Patho-23)
Pharma P4
Pharma-L13 Batch A2: Dr Tamhid (Pharma-17)

W O R K
Patho-L2 Patho-L3
Anti-platelet drugs; Batch A1: SDL
Wed Benign and Malignant Tumors Epidemiology of Cancer
Drugs used in bleeding disorders
06/05/2020 Prof Ahmad Rafiq Prof Ahmad Rafiq
Dr Saleh Patho DSL1
(Pharma-13) (Pharma-13)
(Pharma-13) Batch B1: Dr Nomana (Patho-21)
Batch B2: Dr Maria (Patho-22)
Pharma P4
Pharma-L14 Patho-L5 Batch B2: Dr Tahira (Pharma-17)
Patho-L4
Thrombolytic Carcinogenesis; Batch B1: SDL
Thu Molecular Basis of Cancer
(Fibrinolytic) drugs Types of Carcinogens
07/05/2020 Prof Ahmad Rafiq
Dr Naimat Prof Ahmad Rafiq Patho DSL1
(Pharma-13)
(Pharma-13) (Pharma-13) Batch A1: Dr Maria (Patho-23)
Batch A2: Dr Nomana (Patho-22)
Ramadan
08:00 - 09:00 am 09:00 - 10:00 am 10:00 am - 12:00 pm
Friday Timings

Pharma-L15 Patho-L6
Fri XXXXXXXX
Drugs used in anaemias Clinical Aspects of Neoplasia
08/05/2020 H O S P I T A L W O R K
Dr Naimat Prof Ahmad Rafiq
(Pharma-13) (Pharma-13)

Patho SGD1- Paraneoplastic Syndrome Pharma P4- To prepare and dispense 20 ml of Calamine lotion
Patho DSL1- Tumor immunity
 RD
TIME TABLE OF TOXICOLOGY & SPECIAL MODULE FOR 3 YEAR MBBS (SESSION 2019-20)
WEEK 5
Ramadan 10:15 -
08:00 - 08:45 am 08:45 - 09:30 am 09:30 - 10:15 am 11:45 am - 01:00 pm
Timings 11:45 am
THEME 3: BLOOD CLOT & “CANCER”
Pharma P5
Pharma-L16 Patho-L7 Pharma-L17 Batch A1: Dr Obaida (Pharma-17)
Mon Cancer Chemotherapy I Diagnosis of Cancer Cancer Chemotherapy II Batch A2: Mr Waheed (Pharma-15)
11/05/2020 Prof Saadat Prof Ahmad Rafiq Prof Saadat
(Pharma-13) (Pharma-13) (Pharma-13) Patho P1- Batch B1: Dr Maria (Patho-21)
Batch B2: SDL

H O S P I T A L
Pharma P5
Pharma-L19
Pharma-L18 Patho-L8 Batch B1: Mr Waheed (Pharma-17)
Cancer Chemotherapy IV;
Tue Cancer Chemotherapy III Grading and staging of Tumors Batch B2: Dr Obaida (Pharma-15)
Remedial class
12/05/2020 Prof Saadat Prof Ahmad Rafiq
Prof Saadat
(Pharma-13) (Pharma-13) Patho P1- Batch A1: Dr Zarmina (Patho-22)
(Pharma-13)
Batch A2: SDL
THEME 4: SKIN, EYE & HERBS
Pharma SGD1
Derm-L1 Group 1: Dr Nizam (Pharma-15)
Ophth-L1 Pharma-L20

W O R K
New trends in the treatment of Group 2: Dr Saleh (Pharma-16)
Wed Anti-glaucoma medications Herbal medications
Acne and Melasma Group 3: Dr Muazzam (Pharma-18)
13/05/2020 Dr Tajamul Dr Nizam
Dr Irfan
(Pharma-13) (Pharma-13)
(Pharma-13) Patho P1- Batch B2: Dr Maria (Patho-23)
Batch B1: SDL
Pharma SGD1
Pharma-L21 Ophth-L2 Group 4: Dr Nizam (Pharma-15)
Pharma-L22
Ergot alkaloids & Keratoconus & Group 5: Dr Saleh (Pharma-16)
Thu Eicosanoids
treatment of migraine Corneal Refractive Surgery Group 6: Dr Muazzam (Pharma-18)
14/05/2020 Dr Shandana
Dr Muazzam Dr Zaman
(Pharma-13)
(Pharma-13) (Pharma-13) Patho P1- Batch A2: Dr Zarmina (Patho-21)
Batch A1: SDL
Ramadan
08:00 - 09:00 am 09:00 - 10:00 am 10:00 am - 12:00 pm
Friday Timings

Fri SDL SDL SDL XXXXXXXX

15/05/2020 (Preparation for OSPE) (Preparation for OSPE) (Preparation for OSPE)

Patho P1- Leishmania Pharma P5- To prepare and dispense 20 grams of 5% Sulphur ointment
Pharma SGD1- Comparison of Herbal, Homeopathic, Ayurvedic and Allopathic medicines
 TIME TABLE OF TOXICOLOGY & SPECIAL MODULE FOR 3RD YEAR MBBS (SESSION 2019-20)
WEEK 6

"OSPE WEEK"

10:00 am – 12:00 noon 10:00 am – 12:00 noon 10:00 am – 12:00 noon

Day/Date

PATHOLOGY OSPE PHARMACOLOGY OSPE FORENSIC MEDICINE OSPE

Venue: Department of Venue: Department of Venue: Department of
Pathology Pharmacology Forensic Medicine

Mon
Roll No. 1-50 Roll No. 51-100 Roll No. 101-150
18/05/2020

Tue
Roll No. 151-200 Roll No. 201-250 and onward Roll No. 1-50
19/05/2020

Wed
Roll No. 51-100 Roll No. 101-150 Roll No. 151-200
20/05/2020

Thu
Roll No. 201-250 and onward Roll No. 1-50 Roll No. 51-100
21/05/2020

Fri
Roll No. 101-150 Roll No. 151-200 Roll No. 201-250 and onward
22/05/2020